Restructural changes effective immediately.
The editorial teams of Pharmaceutical Executive and Pharmaceutical Commerce are excited to announce the following updates:
Mike Hollan (MHollan@mjhlifesciences.com) has been named editor of Pharmaceutical Executive, handling the technology and leadership columns, as well as general industry articles and interviews.
Meg Rivers (MRivers@mjhlifesciences.com) has been named managing editor of Pharmaceutical Executive and will be responsible for the day-to-day management and content direction of the brand. Formerly, Meg was the senior editor for our sister brands, Pharmaceutical Technology and BioPharm International, since June 2021. There, she interviewed industry leaders for print and online features, roundtables, and conferences, in addition to managing/co-hosting the biweekly Pharmaceutical Technology podcast, the Drug Solutions Podcast, as well as the Drug Digest video series.
Nico Saraceno (NSaraceno@mjhlifesciences.com) has been promoted to editor of Pharmaceutical Commerce. As associate editor since October 2020, Nico has successfully produced the Pharmaceutical Commerce podcast, taken on increasing responsibilities, and is now leading the day-to-day content management of the brand.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.